These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 7656625)
1. COPD in the elderly. A reversible cause of functional impairment. Chang JT; Moran MB; Cugell DW; Webster JR Chest; 1995 Sep; 108(3):736-40. PubMed ID: 7656625 [TBL] [Abstract][Full Text] [Related]
2. Persistent Empiric COPD Diagnosis and Treatment After Pulmonary Function Test Showed No Obstruction. Fortis S; Corazalla EO; Jacobs DR; Kim HJ Respir Care; 2016 Sep; 61(9):1192-200. PubMed ID: 27165420 [TBL] [Abstract][Full Text] [Related]
3. Residual Volume and Total Lung Capacity to Assess Reversibility in Obstructive Lung Disease. McCartney CT; Weis MN; Ruppel GL; Nayak RP Respir Care; 2016 Nov; 61(11):1505-1512. PubMed ID: 27555617 [TBL] [Abstract][Full Text] [Related]
5. Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease. Hadcroft J; Calverley PM Thorax; 2001 Sep; 56(9):713-20. PubMed ID: 11514693 [TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD. Zheng JP; Yang L; Wu YM; Chen P; Wen ZG; Huang WJ; Shi Y; Wang CZ; Huang SG; Sun TY; Wang GF; Xiong SD; Zhong NS Chest; 2007 Dec; 132(6):1756-63. PubMed ID: 17951625 [TBL] [Abstract][Full Text] [Related]
7. The association between inhaled long-acting bronchodilators and less in-hospital care in newly-diagnosed COPD patients. Kim J; Kim K; Kim Y; Yoo KH; Lee CK; Yoon HK; Kim YS; Park YB; Lee JH; Oh YM; Lee SD; Lee SW Respir Med; 2014 Jan; 108(1):153-61. PubMed ID: 23993445 [TBL] [Abstract][Full Text] [Related]
8. Evaluating How Post-Bronchodilator Vital Capacities Affect the Diagnosis of Obstruction in Pulmonary Function Tests. Blagev DP; Sorenson D; Linares-Perdomo O; Bamberg S; Hegewald M; Morris AH Respir Care; 2016 Nov; 61(11):1523-1529. PubMed ID: 27624631 [TBL] [Abstract][Full Text] [Related]
9. The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease. Zietkowski Z; Kucharewicz I; Bodzenta-Lukaszyk A Respir Med; 2005 Jul; 99(7):816-24. PubMed ID: 15939243 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Wang C; Xu J; Yang L; Xu Y; Zhang X; Bai C; Kang J; Ran P; Shen H; Wen F; Huang K; Yao W; Sun T; Shan G; Yang T; Lin Y; Wu S; Zhu J; Wang R; Shi Z; Zhao J; Ye X; Song Y; Wang Q; Zhou Y; Ding L; Yang T; Chen Y; Guo Y; Xiao F; Lu Y; Peng X; Zhang B; Xiao D; Chen CS; Wang Z; Zhang H; Bu X; Zhang X; An L; Zhang S; Cao Z; Zhan Q; Yang Y; Cao B; Dai H; Liang L; He J; Lancet; 2018 Apr; 391(10131):1706-1717. PubMed ID: 29650248 [TBL] [Abstract][Full Text] [Related]
11. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Belman MJ; Botnick WC; Shin JW Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study. Ulrik CS Thorax; 1995 Jul; 50(7):750-4. PubMed ID: 7570409 [TBL] [Abstract][Full Text] [Related]
13. [Response to inhaled bronchodilators in chronic airway obstruction]. Holten K Tidsskr Nor Laegeforen; 1993 Feb; 113(4):444-7. PubMed ID: 8465284 [TBL] [Abstract][Full Text] [Related]
14. The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD. Dorinsky PM; Reisner C; Ferguson GT; Menjoge SS; Serby CW; Witek TJ Chest; 1999 Apr; 115(4):966-71. PubMed ID: 10208193 [TBL] [Abstract][Full Text] [Related]
15. Albuterol inhalation increases FeNO level in steroid-naive asthmatics but not COPD patients with reversibility. Zhao H; Li R; Lv Y; Dong H; Yao L; Wu Y; Xiao G; Cai S Clin Respir J; 2017 May; 11(3):328-336. PubMed ID: 26077165 [TBL] [Abstract][Full Text] [Related]
16. Treatment of patients with airflow obstruction by general practitioners and chest physicians. van Schayck CP; van Weel C; Folgering H; Verbeek AL; van Herwaarden CL Scand J Prim Health Care; 1989 Oct; 7(3):137-42. PubMed ID: 2587868 [TBL] [Abstract][Full Text] [Related]
17. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data. Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466 [TBL] [Abstract][Full Text] [Related]
18. Bronchodilator response of advanced lung function parameters depending on COPD severity. Jarenbäck L; Eriksson G; Peterson S; Ankerst J; Bjermer L; Tufvesson E Int J Chron Obstruct Pulmon Dis; 2016; 11():2939-2950. PubMed ID: 27932874 [TBL] [Abstract][Full Text] [Related]
19. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Papi A; Romagnoli M; Baraldo S; Braccioni F; Guzzinati I; Saetta M; Ciaccia A; Fabbri LM Am J Respir Crit Care Med; 2000 Nov; 162(5):1773-7. PubMed ID: 11069811 [TBL] [Abstract][Full Text] [Related]
20. Bronchodilator responsiveness in patients with chronic heart failure. Minasian AG; van den Elshout FJ; Dekhuijzen PN; Vos PJ; Willems FF; van den Bergh PJ; Heijdra YF Heart Lung; 2013; 42(3):208-14. PubMed ID: 23273658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]